Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in Radiology

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    January 2022
  1. KANAS AF, Fenelon SS, Santos JMMM, Coelho RF, et al
    Case 297: Mucinous Adenocarcinoma of the Prostate.
    Radiology. 2022;302:238-242.
    PubMed     Abstract available


    December 2021
  2. GOTTLIEB RH
    Introducing a Standard in Prostate Cancer Imaging Evaluation.
    Radiology. 2021 Dec 21:212111. doi: 10.1148/radiol.212111.
    PubMed    


  3. WIBMER AG, Nikolovski I, Chaim J, Lakhman Y, et al
    Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
    Radiology. 2021 Dec 21:210875. doi: 10.1148/radiol.210875.
    PubMed     Abstract available


    November 2021
  4. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021;301:E418.
    PubMed    


    October 2021
  5. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021;301:E380.
    PubMed    


    August 2021
  6. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021 Aug 31:211837. doi: 10.1148/radiol.2021211837.
    PubMed    


  7. MARGEL D, Bernstine H, Groshar D, Ber Y, et al
    Diagnostic Performance of (68)Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.
    Radiology. 2021 Aug 31:204093. doi: 10.1148/radiol.2021204093.
    PubMed     Abstract available


    July 2021
  8. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021 Jul 13:204321. doi: 10.1148/radiol.2021204321.
    PubMed     Abstract available


    May 2021
  9. DENIFFEL D, Healy GM, Dong X, Ghai S, et al
    Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
    Radiology. 2021 May 25:204112. doi: 10.1148/radiol.2021204112.
    PubMed     Abstract available


  10. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021;299:E259.
    PubMed    


  11. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021;299:E258.
    PubMed    


  12. GOLDBERG SN
    More Interventional Oncologic Fire from COLDFIRE-2.
    Radiology. 2021;299:481-482.
    PubMed    


    April 2021
  13. HARMON SA, Gesztes W, Young D, Mehralivand S, et al
    Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
    Radiology. 2021 Apr 13:202425. doi: 10.1148/radiol.2021202425.
    PubMed     Abstract available


  14. COSTA DN
    Multiparametric MRI of the Prostate: Beyond Cancer Detection and Staging.
    Radiology. 2021 Apr 13:204506. doi: 10.1148/radiol.2021204506.
    PubMed    


    March 2021
  15. JADVAR H
    Competitive Advantage of PSMA Theranostics in Prostate Cancer.
    Radiology. 2021 Mar 30:210348. doi: 10.1148/radiol.2021210348.
    PubMed    


  16. LAWHN-HEATH C, Salavati A, Behr SC, Rowe SP, et al
    Prostate-specific Membrane Antigen PET in Prostate Cancer.
    Radiology. 2021 Mar 30:202771. doi: 10.1148/radiol.2021202771.
    PubMed     Abstract available


  17. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021 Mar 9:201852. doi: 10.1148/radiol.2021201852.
    PubMed     Abstract available


    February 2021
  18. TEMPANY-AFDHAL CMC
    Focal Treatment of Prostate Cancer: MRI Helps Guide the Way Forward.
    Radiology. 2021 Feb 2:204333. doi: 10.1148/radiol.2021204333.
    PubMed    


  19. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021 Feb 2:202717. doi: 10.1148/radiol.2021202717.
    PubMed     Abstract available


  20. TEMPANY-AFDHAL CMC, Padhani A, Barentsz J, Weinreb J, et al
    Perspectives and Concerns about PI-RADS and Variability.
    Radiology. 2021;298:E112.
    PubMed    


    November 2020
  21. BAZARGANI S, Bandyk M, Balaji KC
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?
    Radiology. 2020 Nov 3:202870. doi: 10.1148/radiol.2020202870.
    PubMed    


    July 2020
  22. ZUKOTYNSKI KA, Rowe SP
    Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI in Biochemically Recurrent Prostate Cancer.
    Radiology. 2020 Jul 7:202098. doi: 10.1148/radiol.2020202098.
    PubMed    


  23. LINDENBERG L, Mena E, Turkbey B, Shih JH, et al
    Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI.
    Radiology. 2020 Jul 7:192018. doi: 10.1148/radiol.2020192018.
    PubMed     Abstract available


  24. MILOT L
    Variation of PI-RADS Interpretations between Experts: A Significant Limitation.
    Radiology. 2020;296:85-86.
    PubMed    


    June 2020
  25. ZHANG Z, Wu HH, Priester A, Magyar C, et al
    Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology.
    Radiology. 2020 Jun 9:192330. doi: 10.1148/radiol.2020192330.
    PubMed     Abstract available


    May 2020
  26. TAN N, Oyoyo U, Bavadian N, Ferguson N, et al
    PSMA-targeted Radiotracers versus (18)F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
    Radiology. 2020 May 12:191689. doi: 10.1148/radiol.2020191689.
    PubMed     Abstract available


  27. PADHANI AR, Petralia G
    Radiologists Should Integrate Clinical Risk Factors with MRI Findings for Meaningful Prostate Cancer Staging.
    Radiology. 2020 May 5:201082. doi: 10.1148/radiol.2020201082.
    PubMed    


  28. PARK KJ, Kim MH, Kim JK
    Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Radiology. 2020 May 5:192133. doi: 10.1148/radiol.2020192133.
    PubMed     Abstract available


    April 2020
  29. WESTPHALEN AC, McCulloch CE, Anaokar JM, Arora S, et al
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
    Radiology. 2020 Apr 21:190646. doi: 10.1148/radiol.2020190646.
    PubMed     Abstract available


  30. MEYRIGNAC O, Aziza R, Roumiguie M, Malavaud B, et al
    Closing the Gap between Prostate Cancer and Deep Learning Detection Tools.
    Radiology. 2020 Apr 14:200187. doi: 10.1148/radiol.2020200187.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: